Presentation is loading. Please wait.

Presentation is loading. Please wait.

Clinical features of CINCA/NOMID syndrome: (A) band keratinopathy; (B) sensorineural hearing loss; (C) hydrocephalus; (D) migratory urticarial rashes;

Published byAde Gunawan Modified over 5 years ago

Similar presentations

Presentation on theme: "Clinical features of CINCA/NOMID syndrome: (A) band keratinopathy; (B) sensorineural hearing loss; (C) hydrocephalus; (D) migratory urticarial rashes;"— Presentation transcript:

1 Clinical features of CINCA/NOMID syndrome: (A) band keratinopathy; (B) sensorineural hearing loss; (C) hydrocephalus; (D) migratory urticarial rashes; (E) diffuse necrotizing glomerulonephritis with fibrin deposits and (F) mononuclear cell infiltration; (G) pustulosis; and (H, I) excessive hyperostosis of the patella and distal femur. Clinical features of CINCA/NOMID syndrome: (A) band keratinopathy; (B) sensorineural hearing loss; (C) hydrocephalus; (D) migratory urticarial rashes; (E) diffuse necrotizing glomerulonephritis with fibrin deposits and (F) mononuclear cell infiltration; (G) pustulosis; and (H, I) excessive hyperostosis of the patella and distal femur. DARIUS EBRAHIMI-FAKHARI et al. J Rheumatol 2010;37: ©2010 by The Journal of Rheumatology

Download ppt "Clinical features of CINCA/NOMID syndrome: (A) band keratinopathy; (B) sensorineural hearing loss; (C) hydrocephalus; (D) migratory urticarial rashes;"

Similar presentations

U06-16108 #652660020 2 month history of being unwell Vasculitic lesions on lower limbs ANCA positive Likely Wegener’s vs MPA.

U # month history of being unwell Vasculitic lesions on lower limbs ANCA positive Likely Wegener’s vs MPA.

Bone Marrow Edema Syndrome of the Proximal Part of the Femur Following Gastric Bypass Surgery by Martin Siebachmeyer, Paul Fenton, Harinder S. Rai, and.

Bone Marrow Edema Syndrome of the Proximal Part of the Femur Following Gastric Bypass Surgery by Martin Siebachmeyer, Paul Fenton, Harinder S. Rai, and.
Ultrasound Measurements of Torsions in the Tibia and Femur by David Hudson, Todd Royer, and James Richards J Bone Joint Surg Am Volume 88(1):138-143 January.

Ultrasound Measurements of Torsions in the Tibia and Femur by David Hudson, Todd Royer, and James Richards J Bone Joint Surg Am Volume 88(1): January.
Arthroscopy-Associated Complications in Osteosarcoma by John A. Sielatycki, Edward J. Fox, and Elizabeth E. Frauenhoffer JBJS Case Connect Volume 2(4):e68.

Arthroscopy-Associated Complications in Osteosarcoma by John A. Sielatycki, Edward J. Fox, and Elizabeth E. Frauenhoffer JBJS Case Connect Volume 2(4):e68.
Type II Collagen Autoimmunity in Rheumatoid Arthritis

Type II Collagen Autoimmunity in Rheumatoid Arthritis
Figure 1 Pathological features of lupus nephritis subtypes

Figure 1 Pathological features of lupus nephritis subtypes
Figure 2 Risk factors for sarcopenia

Figure 2 Risk factors for sarcopenia
Pre (a) and post (b) contrast agent short-axis images of the third metatarsophalangeal (MTP) joint demonstrating intact capsule and plantar plate (arrows).

Pre (a) and post (b) contrast agent short-axis images of the third metatarsophalangeal (MTP) joint demonstrating intact capsule and plantar plate (arrows).
Selective left coronary angiography demonstrating normal left anterior descending (LAD) and left circumflex arteries and their branches (A). Selective.

Selective left coronary angiography demonstrating normal left anterior descending (LAD) and left circumflex arteries and their branches (A). Selective.
Mean change from baseline in disease and disability outcomes at 6 months for abatacept initiators by anti-CCP status. Mean change from baseline in disease.

Mean change from baseline in disease and disability outcomes at 6 months for abatacept initiators by anti-CCP status. Mean change from baseline in disease.
Expanding the Lauren Classification: A New Gastric Cancer Subtype?

Expanding the Lauren Classification: A New Gastric Cancer Subtype?
Change in secondary endpoints over time: (A) LS mean change from baseline in DAS28-CRP through Week 32, (B) mean change from baseline in CRP through Week.

Change in secondary endpoints over time: (A) LS mean change from baseline in DAS28-CRP through Week 32, (B) mean change from baseline in CRP through Week.
Mean change in patient-reported outcomes from baseline to Week 25 with biweekly or monthly pegloticase compared with placebo. Mean change in patient-reported.

Mean change in patient-reported outcomes from baseline to Week 25 with biweekly or monthly pegloticase compared with placebo. Mean change in patient-reported.
A 61-Year-Old Man With Membranoproliferative Glomerulonephritis

A 61-Year-Old Man With Membranoproliferative Glomerulonephritis
Benefit-risk balance. Benefit-risk balance. Predicted probabilities of developing serious infection versus predicted probabilities of achieving Boolean-based.

Benefit-risk balance. Benefit-risk balance. Predicted probabilities of developing serious infection versus predicted probabilities of achieving Boolean-based.
First-pass perfusion images through the short axis, 2-chamber views.

First-pass perfusion images through the short axis, 2-chamber views.
Percentage of patients achieving minimal disease activity (MDA): A

Percentage of patients achieving minimal disease activity (MDA): A
ACR20, ACR50, and ACR70 response rates during the 12-week study of Japanese patients with rheumatoid arthritis treated with baricitinib or placebo. ACR20,

ACR20, ACR50, and ACR70 response rates during the 12-week study of Japanese patients with rheumatoid arthritis treated with baricitinib or placebo. ACR20,
Changes in PMR-AS, CRP levels, and GC dosage (prednisone) following TCZ therapy in 7 patients with PMR. Since our series included patients with long duration.

Changes in PMR-AS, CRP levels, and GC dosage (prednisone) following TCZ therapy in 7 patients with PMR. Since our series included patients with long duration.

Similar presentations

Ads by Google